Search
Read how a clinical trial is changing the outlook for some people with lung cancer.
A team of researchers from Memorial Sloan Kettering Cancer Center (MSK) and Weill-Cornell Medical College have identified, for the first time, a new molecular pathway that is required for acute myeloid leukemia (AML) development. This work could provide a rationale for targeting the RNA methylation program in myeloid leukemia.
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Giving a two-drug combination before prostate cancer surgery appears to reduce the chance that some high-risk forms of the disease will come back.
Learn about "American Symphony," a documentary featuing a love story, a cancer journey, and a campaign to help save people who need bone marrow donations to fight blood cancer.
Read an interview with Sloan Kettering Institute immunologist Justin Perry.
Memorial Sloan Kettering Cancer Center (MSK) experts presented their latest advances in oncology research at the American Association for Cancer Research (AACR) Annual Meeting 2025, held April 25 to 30 in Chicago.
Hear from our experts about a new study linking alcohol consumption and melanoma risk.
Read about a discovery that a gene linked to pediatric cancers may play an essential role in normal brain development.